Klok FA

ORCID: 0000-0001-9961-0754 · 4 papers in corpus
other 2024
Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial
Research and practice in thrombosis and haemostasis ·doi:10.1016/j.rpth.2024.102448
other 2023
Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study
World journal of gastroenterology ·doi:10.3748/wjg.v29.i21.3328

BACKGROUND: Splanchnic vein thrombosis (SVT) is a major complication of moderate and severe acute pancreatitis. There is no consensus on whether therapeutic anticoagulation should be started in patients with acute pancreatitis and SVT. AIM…

2022
Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
Orphanet journal of rare diseases ·doi:10.1186/s13023-022-02320-x

BackgroundCushing's syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on thromboprophylaxis strategies in patients with CS are currently lacking. We ai…

rct 2018
Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study
BJOG : an international journal of obstetrics and gynaecology ·doi:10.1111/1471-0528.15388

OBJECTIVE: To investigate the characteristics and outcome of abnormal vaginal bleeding in women receiving edoxaban or warfarin for treatment of venous thromboembolism (VTE). DESIGN AND SETTING: Post hoc analysis of the Hokusai-VTE study, a…